GTEC Holdings Ltd. (TSXV: GTEC) (the “Company”), formerly Black Birch Capital Acquisition III Corp. (TSXV: BBC.H), is pleased to announce that it completed its previously announced business combination (the “Transaction”) between the Company and GreenTec Holdings Ltd. (“GreenTec”). In connection with the Transaction, the Company consolidated its common shares on the basis of one post-consolidation share for each 12 pre-consolidation shares (the “Consolidation”) and changed its name to “GTEC Holdings Ltd.”. The Transaction will constitute the Company’s “Qualifying Transaction” pursuant to Policy 2.4 of the TSX Venture Exchange (the “Exchange”) and the Company will carry on the business of GreenTec.
The Exchange issued its conditional approval of the Transaction on May 25, 2018. The Company’s post-Consolidation common shares (the “Common Shares”) will resume trading on the Exchange under the new ticker symbol “GTEC” after the Exchange’s conditions for listing are satisfied and the Exchange issues its final exchange bulletin confirming the completion of the Transaction. The Company, in due course, will advise when the Common Shares will resume trading. For the investors who settled directly with the GreenTec, the Company expects that the TSX Trust will deliver the physical share certificates by the end of next week.
The focus of the Company’s business going forward will be growing, marketing and retailing cannabis in Canada.
Additional information in respect of the Company’s business is available in the Company’s Filing Statement dated May 29, 2018, which is available under the Company’s SEDAR profile at www.sedar.com.
The Company acquired all of the issued and outstanding shares of GreenTec through a three-cornered amalgamation involving a wholly-owned subsidiary of the Company and GreenTec. Pursuant to the Transaction, the Company issued to the shareholders of GreenTec an aggregate of 84,560,916 Common Shares. Outstanding GreenTec common share purchase warrants by their terms become exercisable for an aggregate of 26,113,306 Common Shares. Outstanding GreenTec options by their terms become exercisable for an aggregate of 7,599,247 Common Shares.
With the completion of the Transaction, the Company has 85,741,811 Common Shares issued and outstanding (on an undiluted basis). The principals of the Company and certain shareholders of the Company collectively hold 19,089,227 Common Shares, all of which are subject to a Tier 2 Surplus Security Escrow Agreement pursuant to the policies of the Exchange. In addition, 2,650,000 Common Shares held by non-principals of the Company are subject to a Tier 2 Value Security Escrow Agreement.
In connection with the completion of the Transaction, the Company is pleased to announce its board of directors as follows: Norton Singhavon, Kamaldeep Thindal, Michael Blady, Aaron Dow and Derek Sanders. In addition, the Company is pleased to announce its executive management as follows:
- Norton Singhavon, Chief Executive Officer and Chairman;
- Michael Blady, Vice-President and Secretary;
- Jeremy Wright, Chief Financial Officer;
- David Lynn, Chief Operating Officer; and
- David Buckle, VP Operations.
“Completing the TSX Venture listing is a key milestone for GTEC, as we embark to become Canada’s leading vertically integrated craft cannabis company,” said Norton Singhavon, Chairman and CEO of the Company. Mr. Singhavon further commented, “fulfilling our commitment to become a publicly listed issuer will provide GTEC with access to institutional capital to foster our development and expansion plans within Canada and other federally legalized jurisdictions.”
GreenTec was founded in 2017 to capitalize on opportunities in the nascent and rapidly growing legal cannabis industry. GreenTec is a private corporation based in Kelowna, British Columbia. GreenTec is focused on growing premium quality craft cannabis in purpose-built indoor facilities. GreenTec currently holds a 100% interest in GreenTec Bio-Pharmaceuticals Corp., Grey Bruce Farms Inc., Zenalytic Laboratories Ltd., Falcon Ridge Naturals Ltd., Alberta Craft Cannabis Inc. (formerly Grenex Pharms Inc.), and Tumbleweed Farms Corp.
Investors are cautioned that, except as disclosed in the Filing Statement or Management Information Circular to be prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of the Company should be considered highly speculative.
The TSX Venture Exchange has in no way passed upon the merits of the proposed Transaction and has neither approved nor disapproved the contents of this news release.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The securities of the Company have not been and will not be registered under the United States Securities Act of 1933, as amended and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the trading date of the Common Shares. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE GreenTec Holdings
For further information: GTEC Holdings Ltd., Norton Singhavon, Chief Executive Officer, email@example.com
Meanwhile, two longstanding cannabis partners ended their relationship.
Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development
Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.
The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.
With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.
DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.